Company Profile
KoBioLabs provides microbiome therapeutics for metabolic, immune, and brain diseases. Founded in 2014, the company is based in Seoul, South Korea.
#1649 ๐ฐ๐ท KR
KOSDAQยท348150.KQ
โฉ2800.0000
$1.93ยทโฌ1.69
-9.53% (24h)
Last updated: 1 second ago
Market Cap
โฉ54.37B
$37.46M ยท โฌ32.87M
Volume (24h)
49.13K shrsยท โฉ137.55M
$94.77K ยท โฌ83.15K
Last Close (7D)
โฉ2800.00
$1.93 ยท โฌ1.69
KoBioLabs provides microbiome therapeutics for metabolic, immune, and brain diseases. Founded in 2014, the company is based in Seoul, South Korea.
52-Week Range
SEC filings for this ticker are not available yet.
Americas
Europe
Asia